Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2A6 | P11509 | 3/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.32 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13022174 | 1.00 | CYP2A6 (0.33) | CYP2A6CYP1A2MAPTSMN1; SMN2NPSR1 | |
| SCHEMBL13022243 | 0.96 | CYP2A6 (0.36) | CYP2A6CYP1A2MAPTSMN1; SMN2NPSR1 | |
| SCHEMBL13022236 | 0.96 | CYP2A6 (0.36) | CYP2A6CYP1A2MAPTSMN1; SMN2NPSR1 | |
| SCHEMBL13022237 | 0.96 | CYP2A6 (0.36) | CYP2A6CYP1A2MAPTSMN1; SMN2NPSR1 | |
| SCHEMBL13022892 | 0.92 | MAPT (0.39) | CYP2A6MAPTSMN1; SMN2NPSR1TDP1 | |
| SCHEMBL13022172 | 0.92 | MAPT (0.34) | CYP2A6CYP1A2MAPTSMN1; SMN2NPSR1 | |
| SCHEMBL13022923 | 0.92 | CYP2A6 (0.40) | CYP2A6CYP1A2MAPTSMN1; SMN2NPSR1 | |
| SCHEMBL13022168 | 0.92 | MAPT (0.34) | CYP2A6CYP1A2MAPTSMN1; SMN2NPSR1 | |
| SCHEMBL13022924 | 0.92 | CYP2A6 (0.40) | CYP2A6CYP1A2MAPTSMN1; SMN2NPSR1 | |
| SCHEMBL13022890 | 0.91 | MAPT (0.42) | CYP2A6CYP1A2MAPTSMN1; SMN2NPSR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100286360-A1 | POLYMER COMPOUND AND POLYMER LIGHT EMITTING DEVICE USING THE SAME | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2010-11-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100286360-A1 | POLYMER COMPOUND AND POLYMER LIGHT EMITTING DEVICE USING THE SAME | IGF1R, SCO2, CRY1 | CYP2A6 2054/4885CYP1A2 813/4885MAPT 2367/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.